SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-339945
Filing Date
2018-11-30
Accepted
2018-11-30 17:27:13
Documents
5
Period of Report
2018-11-30

Document Format Files

Seq Description Document Type Size
1 6-K d666988d6k.htm 6-K 12023
2 EX-99.1 d666988dex991.htm EX-99.1 9015
3 EX-99.2 d666988dex992.htm EX-99.2 191404
4 EX-99.3 d666988dex993.htm EX-99.3 13536
5 GRAPHIC g666988auriniapharmaceutical.jpg GRAPHIC 4768
  Complete submission text file 0001193125-18-339945.txt   233719
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 181212101
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1